Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22401188 | 0.75 | — | — | |
| SCHEMBL557226 | 0.74 | — | — | |
| SCHEMBL28345417 | 0.70 | OPRD1 (0.31) | — | |
| SCHEMBL6099999 | 0.68 | MEN1 (0.35) | — | |
| SCHEMBL11564684 | 0.67 | HIF1A (0.33) | ADRB1ALDH1A1LMNA | |
| SCHEMBL3317716 | 0.67 | CXCR4 (0.32) | — | |
| SCHEMBL2728754 | 0.66 | CA2 (0.34) | — | |
| SCHEMBL3324302 | 0.66 | CXCR4 (0.32) | — | |
| Hydrochloric Acid SCHEMBL27445441 | 0.65 | ALDH1A1 (0.35) | ALDH1A1LMNA | |
| SCHEMBL2931839 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12502386-B2 | Nitrogen-containing heterocyclic compound and use thereof | Shanghai Shijiang Biotechnology Co., Ltd. (CN) | 2025-12-23 | — | — | US | claimed |
| US-20250197389-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | SHANGHAI SHIJIANG BIOTECHNOLOGY CO., LTD (CN) | 2025-06-19 | — | — | US | claimed |
| US-20250197415-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF | SHANGHAI SHIJIANG BIOTECHNOLOGY CO., LTD (CN) | 2025-06-19 | — | — | US | claimed |
| US-12502386-B2 | Nitrogen-containing heterocyclic compound and use thereof | Shanghai Shijiang Biotechnology Co., Ltd. (CN) | 2025-12-23 | — | — | US | disclosed |
| US-20250197389-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | SHANGHAI SHIJIANG BIOTECHNOLOGY CO., LTD (CN) | 2025-06-19 | — | — | US | disclosed |
| US-20250197415-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF | SHANGHAI SHIJIANG BIOTECHNOLOGY CO., LTD (CN) | 2025-06-19 | — | — | US | disclosed |
| EP-4495116-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | Shanghai Shijiang Biotechnology Co., Ltd (CN) | 2025-01-22 | — | — | EP | disclosed |
| EP-4495117-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF | Shanghai Shijiang Biotechnology Co., Ltd (CN) | 2025-01-22 | — | — | EP | disclosed |
| CN-117813305-A | Nitrogen-containing heterocyclic compound and application thereof | 南京施江医药科技有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117529480-A | Nitrogen-containing heterocyclic compound | 南京施江医药科技有限公司 | 2024-02-06 | — | — | CN | disclosed |
| WO-2023174381-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF | 南京施江医药科技有限公司 | 2023-09-21 | — | — | WO | disclosed |
| WO-2023174378-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | 南京施江医药科技有限公司 | 2023-09-21 | — | — | WO | disclosed |
| CN-104955824-B | It is used as the aminopyrimidine compounds of the inhibitor of the EGFR mutant containing T790M | 豪夫迈·罗氏有限公司 | 2017-09-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250197389-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | PPIF, PIN1, NME4 | ADRB1 4671/4885ALDH1A1 3141/4885LMNA 2301/4885 |
| US-20250197415-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF | UHRF1, NNMT, EHMT1 | ADRB1 3508/4885ALDH1A1 956/4885LMNA 4217/4885 |
| US-12502386-B2 | Nitrogen-containing heterocyclic compound and use thereof | UHRF1, NNMT, EHMT1 | ADRB1 3508/4885ALDH1A1 956/4885LMNA 4217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.